Oligonucleotide conjugated antibody strategies for cyclic immunostainingJocelyn Jones, Summer L. Gibbs, Koei Chin et al.|Scientific Reports|2021Cited by 42
Sensitivity to targeted therapy differs between HER2-amplified breast cancer cells harboring kinase and helical domain mutations in PIK3CAJoseph P. Garay, James E. Korkola, Rebecca Smith et al.|Breast Cancer Research|2021Cited by 21